Loading stock data…
Seer (SEER)
$1.66
After Hours$1.67+0.01 (+0.60%)· Last close Jun 29
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Seer, Inc. in the Healthcare sector is trading at $1.66 with a market capitalization of $95M. Wall Street consensus targets $4.00 (1 analysts), implying a +141.0% move over the next 12 months. The stock is currently near its 52-week low of $1.65, remaining 13.5% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +141.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 32) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.71M↓ | $4.07M↑ | $3.97M↑ | $3.93M↓ | $4.14M |
| Gross Profit | $895,000↓ | $2.06M↑ | $1.96M↓ | $1.99M↓ | $2.00M |
| Operating Income | -$17.26M↑ | -$17.39M↑ | -$19.35M↑ | -$20.53M↑ | -$20.73M |
| Net Income | -$16.84M↓ | -$15.99M↑ | -$18.23M↑ | -$19.42M↑ | -$19.95M |
Peer Comparison
JNJUNHPFE
Fundamentals
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Pr...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$95.12M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-29.19%
Volume
Today's trading volume
213,543
Recent News
Seer, Inc. Q1 2026 Earnings Call Summary
Moby summary of Seer, Inc.'s Q1 2026 earnings call
Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Revenue Decline Amid Competitive ...
Despite a challenging quarter with decreased revenue and gross margin, Seer Inc (SEER) remains optimistic about future growth through strategic collaborations and innovation.
Seer Q1 Earnings Call Highlights
Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and expected second-half consumables demand as supports for the year. Total revenue for the quarter ended
Full Transcript: Seer Q1 2026 Earnings Call
Seer (NASDAQ:SEER) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive financial data and transcripts, visit https://www.benzinga.com/apis/. The full earnings call is available at https://edge.media-server.com/mmc/p/krwrnxpf Summary Seer reported Q1 2026 total revenue of $2.8 million, a decline from $4.2 million in Q1 2025, mainly due to macroeconomic headwinds in academic fundin
How Seer (SEER) Is Rewriting Its Story With New Targets And Activist Pressure
Seer’s analyst price target has shifted from US$3.29 to US$4.00, changing the implied upside that some investors will be watching closely. Supportive analysts link this new US$4.00 level to updated assumptions on growth potential and profitability, while more cautious voices flag how much it relies on specific expectations being met. As you read on, you will see how this revised target fits into the latest activist activity and how to track the story as it develops. Analyst Price Targets...